Stock Market News

7 hours Eli Lilly and Novo Nordisk’s Obesity Moat Just Got StrongerThe Wall Street Journal

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

Amgen (AMGN) · Biotech · Eli Lilly (LLY)

7 hours Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?The Motley Fool X

7 hours Warning: This Skyrocketing Stock Has a Hidden RiskThe Motley Fool X

9 hours Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%The Motley Fool X

9 hours Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%Yahoo Finance X

24 hours Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & MoreZacks X

24 hours Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell?Zacks X

1 day Why Is Lilly (LLY) Down 5% Since Last Earnings Report?Zacks X

1 day Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

1 day Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should KnowZacks X

1 day Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?The Motley Fool X

1 day Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?Yahoo Finance X

2 days Here’s Yet Another Reason to Buy Viking Therapeutics Stock Like There’s No TomorrowThe Motley Fool X

2 days Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade)Seeking Alpha X

2 days Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?The Motley Fool X

3 days Biotech ETF (XBI) ended a diagonal – Looking for buying dipsFXStreet X

3 days AMGN Stock Down Despite Strong Data From Obesity Drug StudyZacks X

3 days Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and DisneyYouTube X

3 days Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool YouSeeking Alpha X

3 days LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity DrugsZacks X

3 days Corcept Therapeutics: A Most Promising And Compelling BiotechSeeking Alpha X

3 days Is Iovance Biotherapeutics Stock a Millionaire Maker?The Motley Fool X

3 days Amgen: Checks All The Wrong BoxesSeeking Alpha X

3 days Why Amgen’s Weight Loss Result Is a Win for Eli LillyThe Motley Fool X

4 days Final Trade: JWN, IWM, GCO, AMGNYouTube X

4 days Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher RaymondYouTube X

4 days A Post-Mortem on Cassava SciencesZacks X

4 days Amgen stock sinks as weightloss drug fails to impressFXStreet X

4 days Amgen: MariTide Underwhelms, But There Are Ways To WinSeeking Alpha X

4 days Chart of the Day: AmgenYouTube X

4 days Eli Lilly, Amazon lead market cap stock movers on TuesdayInvesting.com X

4 days Cramer’s Stop Trading: AmgenYouTube X

4 days Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.Yahoo Finance X

4 days Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity TreatmentInvestor's Business Daily X

4 days Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.Yahoo Finance X

4 days Amgen says obesity drug caused up to 20% weight loss after a year, with no plateauYouTube X

4 days These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and MoreYahoo Finance X

5 days Mizuho’s Jared Holz on what Trump’s FDA pick means for biotech innovationYouTube X

5 days Ecolab Inc. (ECL): Leveraging Clean Tech, High Tech, and Biotech for Sustained Growth and Margin ExpansionInsider Monkey X

5 days Finding Winners In Biotech, Probably The Riskiest SectorSeeking Alpha X

5 days Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goalsMarketWatch X

6 days Eli Lilly’s (LLY) Breakthroughs: Hedge Funds’ New Healthcare FavoriteInsider Monkey X

1 week Eli Lilly: Steep Pullback, Still Compelling HereSeeking Alpha X

1 week Eli Lilly: Steep Pullback, Still Compelling HereSeeking Alpha X

1 week Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?The Motley Fool X

1 week Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?The Motley Fool X

1 week Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?Yahoo Finance X

1 week 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise MoveThe Motley Fool X

1 week Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks X

1 week Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?The Motley Fool X

1 week RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?Investor's Business Daily X

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.